1) histamine releasing activity(HRA)
组织胺释放活性
2) histamine-releasing activity
组胺释放活性
1.
Objective:To determine the positivity rate of anti-FcεR I α auto-antibodies in chronic urticaria and to explore the relationship between the histamine-releasing activity and anti-FcεRⅠα auto-antibodies.
目的:了解慢性荨麻疹患者血清抗FcεRⅠα自身抗体的阳性率,探讨慢性荨麻疹患者血清中组胺释放活性与抗FcεRⅠα自身抗体的关系。
3) Histamine release
组胺释放
1.
Relationship between substance P and histamine release of mast cells in human hypertrophic scar;
P物质对增生性瘢痕中肥大细胞组胺释放的影响
2.
Evaluation of histamine-releasing activity in the sera of patients with primary acquired cold urticaria by histamine release assay of mast cells in vitro;
寒冷性荨麻疹患者血清组胺释放活性检测
3.
Histamine release and hemodynamic changes caused by cisatracurium;
顺式阿曲库铵的组胺释放作用及其对血液动力学的影响
4) Histamine Sensitization Activity
组织胺致敏活性
1.
Study by Studying on the two different Histamine Sensitization Activity for Acellular Pertussis Vaccine;
无细胞百日咳疫苗中两种不同组织胺致敏活性比较
5) tissue feed enzyme
组织释放酶
6) granuliberin
组胺颗粒释放素
补充资料：白细胞组织胺释放试验
白细胞组织胺释放试验
leucocyte histamine veleaze test
测定Ⅰ型变态反应患者周围血中嗜碱细胞上IgE量的一种方法。分离出白细胞，加入变应原培养，确定从白细胞中释放出50%组胺所需加入的变应原量。本法结果一般与皮肤试验相符，但不及后者敏感。优点是体外操作，比较安全，且是定量测定。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条